• Updated

MISSOULA, Mont., Nov. 12, 2019 /PRNewswire/ -- Expesicor, a privately held, Montana-based company focused on preventing, treating, and curing neurological disorders, announced its participation in the National Institutes of Health's (NIH) Helping to End Addiction Long-term Initiative or NIH HEAL Initiative. The Initiative takes an "all hands on deck" approach "to improve prevention and treatment strategies for opioid misuse and addiction and to enhance pain management." Expesicor has been awarded $407,654 over one year for a grant that allows the company to further develop a novel positron emission tomography (PET) imaging agent, called EXP-1801, that enables the visualization and objective measurement of pain. This technology is applicable to both personalized pain treatment and the development of novel pain management therapies, such as non-opioid medications.

  • Updated

LIVINGSTON, Mont., Nov. 12, 2019 /PRNewswire/ -- PFL announced today new C-level executive appointments to support the strong global growth and demand for its tactile marketing automation solutions. Daniel Gaugler, who served as PFL's CMO for the last eight years, has been promoted to Chief Product and Innovation Officer. Nick Runyon, a seasoned executive with over 20 years of global marketing experience has been named Chief Marketing Officer.

  • Updated

HELENA — The Montana Department of Commerce spends millions in bed tax revenues each year to promote the state as a tourism destination for out-of-state visitors and to support tourism-related infrastructure in Montana. A legislative audit of the department’s 2017 fiscal year presented last week sought, in part, to determine how effectively that money is spent.